Could the Yankees find a match for Ichiro Suzuki in the Phillies?

44 Comments

ESPN’s Buster Olney tweeted earlier that Ichiro Suzuki appears to be the odd man out in the Yankees’ outfield and adds that the Phillies could use outfield help. The Yankees, of course, will have recent free agent additions Jacoby Ellsbury and Carlos Beltran in center and right, respectively, and Brett Gardner in left. Alfonso Soriano would back up in either corner while Gardner can move back to center in a pinch.

The Phillies don’t have a starting spot for Ichiro, but could put him on the bench. GM Ruben Amaro said during the off-season that he prefers to have a left-handed hitting outfielder capable of playing center field, but those were scarce throughout the off-season. He did add Bobby Abreu, but outside of drawing a few walks, he has had a disappointing spring to date, hitting just .111 in 18 at-bats.

That being said, there doesn’t seem to be a strong match considering that the Phillies are right up against the $189 million luxury tax when everything is factored in. The Yankees would have to pay just about the entirety of his $6.5 million salary or take back an equally-expensive player in return, such as reliever Mike Adams ($7 million) who is recovering from a torn rotator cuff and two labrum tears.

The Phillies adding the 40-year-old to their roster, though, would make for a fresh source of age-related jokes at their expense.

Report: Some MLB teams using outside labs for COVID-19 testing

MLB COVID-19 testing
Jason Koerner/Getty Images
Leave a comment

The Athletic’s Ken Rosenthal and Zach Buchanan report that the Diamondbacks are one of several teams that have used labs other than the Sports Medicine Research and Testing Laboratory in Utah to process COVID-19 testing. MLB has encountered delays with its testing, despite promising 24-hour turnaround time, so teams have tried other avenues — with the league’s endorsement — in order to get faster results.

The SMRTL had processed performance-enhancing drug screenings for MLB. The league converted it to process COVID-19 tests amid concerns that having a season and all of the testing that would be required throughout would take away testing resources from the general public. That some teams are utilizing labs other than the SMRTL suggests the league, indeed, is usurping those resources.

In prospect Seth Beer’s case, he tested positive for COVID-19. He needed to test negative twice consecutively to be cleared to return to play. Beer went to a third-party site in the Phoenix area. He received his second negative test and was cleared to return on July 9.

The Diamondbacks said that the labs they have used have assured them that they are not taking away tests from the public. That seems like a claim MLB and the D-Backs should demonstrably prove. Per Rosenthal and Buchahan, the D-Backs have gone to an outside lab about 20 times, which accounts for less than one percent of COVID-19 tests taken by players and staff. Still, those are 20 tests that could have been used by the general public. And if the D-Backs and a handful of other teams already are using outside labs, then the rest of the league likely already is or soon will be doing the same. In the end, there will be a lot more than 20 tests taken at outside labs by MLB players and staff. Considering that “Tier 1” players will be tested every other day throughout the season, the total of third-party tests taken — if things continue the way they are now — could easily reach into the thousands by the end of October.

We all want baseball back, but the players, coaches, and all other staff are no more important than cashiers, teachers, and delivery drivers, so they shouldn’t have more access to COVID-19 testing simply by virtue of being associated with Major League Baseball and all of its influence and financial muscle. It would be unethical for MLB to be cutting in line ahead of other people who need testing just as much as if not more than the players.